Literature DB >> 16915303

A retrospective study of the relationship between biomarkers of atherosclerosis and erectile dysfunction in 988 men.

C B Eaton1, Y L Liu, M A Mittleman, M Miner, D B Glasser, E B Rimm.   

Abstract

Erectile dysfunction (ED) is associated with clinical atherosclerosis and several atherosclerotic risk factors including smoking, hypertension, dyslipidemia, diabetes mellitus, obesity and sedentary lifestyle. Clinical atherosclerosis is also associated with these same risk factors and with biomarkers of inflammation, thrombosis, endothelial cell activation. We evaluated the cross-sectional association between the degree of ED and levels of atherosclerotic biomarkers. A subcohort of 988 US male health professionals between the ages 46 and 81 years as part of an ongoing epidemiologic study had atherosclerotic biomarkers measured from blood collected in 1994-1995. These same men had in 2000, been retrospectively asked about erectile function in 1995 and in 2000. Biennial questionnaires since 1986 assessed medical conditions, medications, smoking, physical activity, body mass index, alcohol intake. The retrospective assessment of erectile function in 2000 for 1995 in these 988 men ranged from very good - 28.2%, good - 25.1%, fair - 19.2%, poor - 13.6%, to very poor - 13.9%. Men with poor to very poor erectile function compared to men with good and very good erectile function had 2.9 the odds of having elevated Factor VII levels (P=0.03), 1.9 times the odds of having elevated vascular cell adhesion molecule (P=0.13) and 2.0 times the odds of having elevated intracellular adhesion molecule (P=0.06) and 2.1 times the odds of having elevated total cholesterol/high-density lipoprotein ratio (P=0.02) comparing the top to bottom quintiles for each atherosclerotic biomarker after multivariate adjustment. Lipoprotein(a), homocysteine, interleukin-6 and tumor necrosis factor receptor, C-reactive protein and fibrinogen were not associated with the degree of erectile function after adjustment. We conclude that selected biomarkers for endothelial function, thrombosis and dyslipidemia but not inflammation are associated with the degree of ED in this cross-sectional analysis. Future studies evaluating the prospective association of ED, endothelial function and cardiovascular disease appear warranted.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16915303     DOI: 10.1038/sj.ijir.3901519

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  17 in total

1.  Metabolic syndrome and urologic diseases.

Authors:  Ilya Gorbachinsky; Haluk Akpinar; Dean G Assimos
Journal:  Rev Urol       Date:  2010

Review 2.  Emerging role for TNF-α in erectile dysfunction.

Authors:  Fernando S Carneiro; Robert Clinton Webb; Rita C Tostes
Journal:  J Sex Med       Date:  2010-12       Impact factor: 3.802

3.  The correlation between high sensitivity C-reactive protein and erectile dysfunction patients with hypertension treated with vardenafil.

Authors:  S Azab; H Aoud; N Nabil
Journal:  Int J Impot Res       Date:  2016-12-01       Impact factor: 2.896

4.  Association Between Erectile Function and Biomarkers of Subclinical Atherosclerosis: A Study Based on Middle-Aged Healthy Men from the General Population.

Authors:  Saad Elzanaty; Babak Rezanezhad; Ronnie Willenheimer; Rasmus Borgquist
Journal:  Curr Urol       Date:  2016-09-20

5.  Reversal of diabetic vasculopathy in a rat model of type 1 diabetes by opiorphin-related peptides.

Authors:  Giulia Calenda; Yuehong Tong; Nirmala D Kanika; Moses T Tar; Sylvia O Suadicani; Xinhua Zhang; Arnold Melman; Catherine Rougeot; Kelvin P Davies
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-07-22       Impact factor: 4.733

6.  A population-based, longitudinal study of erectile dysfunction and future coronary artery disease.

Authors:  Brant A Inman; Jennifer L St Sauver; Debra J Jacobson; Michaela E McGree; Ajay Nehra; Michael M Lieber; Véronique L Roger; Steven J Jacobsen
Journal:  Mayo Clin Proc       Date:  2009-02       Impact factor: 7.616

Review 7.  Diabetes, obesity and erectile dysfunction: field overview and research priorities.

Authors:  Kanchan Chitaley; Varant Kupelian; Leslee Subak; Hunter Wessells
Journal:  J Urol       Date:  2009-12       Impact factor: 7.450

Review 8.  The role of opiorphins (endogenous neutral endopeptidase inhibitors) in urogenital smooth muscle biology.

Authors:  Kelvin Paul Davies
Journal:  J Sex Med       Date:  2009-03       Impact factor: 3.802

9.  Non-steroidal anti-inflammatory drug (NSAID) use is not associated with erectile dysfunction risk: results from the Prostate Cancer Prevention Trial.

Authors:  Darshan P Patel; Jeannette M Schenk; Amy Darke; Jeremy B Myers; William O Brant; James M Hotaling
Journal:  BJU Int       Date:  2015-09-20       Impact factor: 5.588

Review 10.  Association Between Periodontal Disease and Erectile Dysfunction: A Systematic Review.

Authors:  Sergio Varela Kellesarian; Tammy Varela Kellesarian; Vanessa Ros Malignaggi; Mansour Al-Askar; Alexis Ghanem; Hans Malmstrom; Fawad Javed
Journal:  Am J Mens Health       Date:  2016-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.